G Larry Maxwell
Overview
Explore the profile of G Larry Maxwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
2361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kucera C, Chappell N, Tian C, Richardson M, Tarney C, Hamilton C, et al.
Gynecol Oncol
. 2024 Feb;
184:224-235.
PMID: 38340648
Purpose: We investigated racial disparities in survival by histology in cervical cancer and examined the factors contributing to these disparities. Methods: Non-Hispanic Black and non-Hispanic White (hereafter known as Black...
12.
Winkler S, Tian C, Casablanca Y, Bateman N, Jokajtys S, Kucera C, et al.
Gynecol Oncol
. 2024 Jan;
184:31-42.
PMID: 38277919
Objective: This study investigated the risk of an aggressive endometrial cancer (EC) diagnosis by race, ethnicity, and country of origin to further elucidate histologic disparities in non-Hispanic Black (NHB), Hispanic,...
13.
Hunt A, Bateman N, Barakat W, Makohon-Moore S, Abulez T, Driscoll J, et al.
Clin Proteomics
. 2024 Jan;
21(1):4.
PMID: 38254014
Background: Although uterine serous carcinoma (USC) represents a small proportion of all uterine cancer cases, patients with this aggressive subtype typically have high rates of chemotherapy resistance and disease recurrence...
14.
Buddenkotte T, Rundo L, Woitek R, Escudero Sanchez L, Beer L, Crispin-Ortuzar M, et al.
Eur Radiol Exp
. 2023 Dec;
7(1):77.
PMID: 38057616
Purpose: To determine if pelvic/ovarian and omental lesions of ovarian cancer can be reliably segmented on computed tomography (CT) using fully automated deep learning-based methods. Methods: A deep learning model...
15.
McGee J, Su P, Durbin K, Hollas M, Bateman N, Maxwell G, et al.
Nat Commun
. 2023 Dec;
14(1):7946.
PMID: 38040721
No abstract available.
16.
Corvigno S, Badal S, Spradlin M, Keating M, Pereira I, Stur E, et al.
NPJ Precis Oncol
. 2023 Nov;
7(1):115.
PMID: 37923835
In this study, we investigated the metabolic alterations associated with clinical response to chemotherapy in patients with ovarian cancer. Pre- and post-neoadjuvant chemotherapy (NACT) tissues from patients with high-grade serous...
17.
McGee J, Su P, Durbin K, Hollas M, Bateman N, Maxwell G, et al.
Nat Commun
. 2023 Oct;
14(1):6478.
PMID: 37838706
The molecular identification of tissue proteoforms by top-down mass spectrometry (TDMS) is significantly limited by throughput and dynamic range. We introduce AutoPiMS, a single-ion MS based multiplexed workflow for top-down...
18.
Teng P, Barakat W, Tran S, Tran Z, Bateman N, Conrads K, et al.
Transl Psychiatry
. 2023 Oct;
13(1):318.
PMID: 37833300
Alcohol use disorder (AUD) affects transcriptomic, epigenetic and proteomic expression in several organs, including the brain. There has not been a comprehensive analysis of altered protein abundance focusing on the...
19.
Ao W, Kim H, Tommarello D, Conrads K, Hood B, Litzi T, et al.
Gynecol Oncol
. 2023 Aug;
177:60-71.
PMID: 37639904
Objective: ATR kinase inhibitors promote cell killing by inducing replication stress and through potentiation of genotoxic agents in gynecologic cancer cells. To explore mechanisms of acquired resistance to ATRi in...
20.
Nguyen A, Murrin E, Nasrallah S, Hitchings L, Wang J, Vandillen M, et al.
Pediatr Infect Dis J
. 2023 Jun;
42(9):781-786.
PMID: 37260248
Background: Pregnant patients with coronavirus disease 2019 (COVID-19) are at risk for adverse pregnancy outcomes. Although clinical outcomes for pregnant adults have been reported, the impact of COVID-19 on adolescents...